{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:38:31Z","timestamp":1781534311619,"version":"3.54.5"},"reference-count":20,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>In some instances the standard method of doing molecular testing from formalin-fixed, paraffin-embedded block is not possible because of limited tissue. Tumor cell\u2013enriched cell-transfer technique has been proven useful for performing immunocytochemistry and molecular testing on cytologic smears.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To establish the cell-transfer technique as a viable option for isolating tumor cells from hematoxylin-eosin (H&amp;E)\u2013stained slides.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Molecular testing was performed by using the cell-transfer technique on 97 archived H&amp;E-stained slides from a variety of different tumors. Results were compared to the conventional method of molecular testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Polymerase chain reaction\u2013based molecular testing via the cell-transfer technique was successfully performed on 82 of 97 samples (85%). This included 39 of 47 cases for EGFR, 10 of 11 cases for BRAF, and 33 of 39 cases for KRAS mutations. Eighty-one of 82 cell-transfer technique samples (99%) showed agreement with previous standard method results, including 4 mutations and 35 wild-type alleles for EGFR, 4 mutations and 6 wild-type alleles for BRAF, and 11 mutations and 21 wild-type alleles for KRAS. There was only 1 discrepancy: a cell-transfer technique with a false-negative &amp;gt;KRAS result (wild type versus G12C).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Molecular testing performed on H&amp;E-stained sections via cell-transfer technique is useful when tissue from cell blocks and small surgical biopsy samples is exhausted and the only available material for testing is on H&amp;E-stained slides.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2015-0454-oa","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T21:49:07Z","timestamp":1463694547000},"page":"1383-1389","source":"Crossref","is-referenced-by-count":12,"title":["Utilization of Cell-Transfer Technique for Molecular Testing on Hematoxylin-Eosin\u2013Stained Sections: A Viable Option for Small Biopsies That Lack Tumor Tissues in Paraffin Block"],"prefix":"10.5858","volume":"140","author":[{"given":"Howard H.","family":"Wu","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Jovonovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyashree D.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Curless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"issue":"3","key":"2020081222264207300_i1543-2165-140-12-1383-b01","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"2020081222264207300_i1543-2165-140-12-1383-b02","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"2020081222264207300_i1543-2165-140-12-1383-b03","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1349-7006.2007.00607.x","article-title":"Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer","volume":"98","author":"Mitsudomi","year":"2007","journal-title":"Cancer Sci"},{"issue":"21","key":"2020081222264207300_i1543-2165-140-12-1383-b04","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"issue":"5676","key":"2020081222264207300_i1543-2165-140-12-1383-b05","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"issue":"36","key":"2020081222264207300_i1543-2165-140-12-1383-b06","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2020081222264207300_i1543-2165-140-12-1383-b07","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence","volume":"23","author":"Mitsudomi","year":"2005","journal-title":"J Clin Oncol"},{"issue":"34","key":"2020081222264207300_i1543-2165-140-12-1383-b08","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1200\/JCO.2008.16.7254","article-title":"EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan","volume":"26","author":"Takano","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"2020081222264207300_i1543-2165-140-12-1383-b09","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10585-012-9488-y","article-title":"Dividing and conquering: controlling advanced melanoma by targeting oncogene-defined subsets","volume":"29","author":"Flaherty","year":"2012","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"2020081222264207300_i1543-2165-140-12-1383-b10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/dc.22897","article-title":"ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies","volume":"41","author":"Ferguson","year":"2013","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"2020081222264207300_i1543-2165-140-12-1383-b11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1309\/AJCP8O7VIGSIXIVS","article-title":"Immunocytochemistry performed on the cell-transferred direct smears of the fine-needle aspirates: a comparison study with the corresponding formalin-fixed paraffin-embedded tissue","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"2020081222264207300_i1543-2165-140-12-1383-b12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/modpathol.2013.220","article-title":"Utilization of cell-transferred cytologic smears in detection of EGFR and KRAS mutation on adenocarcinoma of lung","volume":"27","author":"Wu","year":"2014","journal-title":"Mod Pathol"},{"issue":"12","key":"2020081222264207300_i1543-2165-140-12-1383-b13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/cncy.21469","article-title":"The usefulness of the cell transfer technique for immunocytochemistry of fine-needle aspirates","volume":"122","author":"Marshall","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"2020081222264207300_i1543-2165-140-12-1383-b14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000368273","article-title":"Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears","volume":"58","author":"Chen","year":"2014","journal-title":"Acta Cytol"},{"issue":"4","key":"2020081222264207300_i1543-2165-140-12-1383-b15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1309\/AJCP5BG0KUEOJCVS","article-title":"Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique","volume":"143","author":"Shi","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2020081222264207300_i1543-2165-140-12-1383-b16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000430083","article-title":"Anaplastic lymphoma kinase immunocytochemistry on cell-transferred cytologic smears of lung adenocarcinoma","volume":"59","author":"Zhang","year":"2015","journal-title":"Acta Cytol"},{"issue":"6","key":"2020081222264207300_i1543-2165-140-12-1383-b17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.5858\/arpa.2012-0367-OA","article-title":"Validation of companion diagnostic for detection of mutations in codons 12 and 13 of the KRAS gene in patients with metastatic colorectal cancer: analysis of the NCIC CTG CO.17 trial","volume":"137","author":"Harbison","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"2020081222264207300_i1543-2165-140-12-1383-b18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/11751","article-title":"Detection of PCR products using self-probing amplicons and fluorescence","volume":"17","author":"Whitcombe","year":"1999","journal-title":"Nat Biotechnol"},{"issue":"19","key":"2020081222264207300_i1543-2165-140-12-1383-b19","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1093\/nar\/28.19.3752","article-title":"Mode of action and application of Scorpion primers to mutation detection","volume":"28","author":"Thelwell","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2020081222264207300_i1543-2165-140-12-1383-b20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.5858\/arpa.2012-0720-OA","article-title":"Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology","volume":"137","author":"Lindeman","year":"2013","journal-title":"Arch Pathol Lab Med"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/12\/1383\/1615574\/arpa_2015-0454-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/12\/1383\/1615574\/arpa_2015-0454-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:35:09Z","timestamp":1764790509000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/12\/article-p1383.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,5,19]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2015-0454-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]}}}